Senti Biosciences Holdings, Inc. (SNTI): Form 8-K filed 2026-07-15

Accepted by EDGAR

2026-07-15 07:32 ET

Event date

2026-07-14

Accession no.

0001628280-26-048248

Original filing

SEC EDGAR filing index

Items reported

• Item 1.01: Entry into a Material Definitive Agreement
  The company signed a material agreement outside the ordinary course of business, or materially amended one. Typical examples are credit agreements, merger agreements, large supply or licensing contracts and financing arrangements.
• Item 2.02: Results of Operations and Financial Condition
  The company publicly announced results of operations or financial condition for a completed period, most often a quarterly earnings release. The release itself is usually attached as Exhibit 99.1. Information under Item 2.02 is generally "furnished" rather than "filed".
• Item 5.01: Changes in Control of Registrant
  A change in control of the company occurred, for example through an acquisition of a controlling stake.
• Item 7.01: Regulation FD Disclosure
  The company is making information public under Regulation FD, which requires broad public disclosure of material information shared with certain market participants. Investor presentations and press releases are common. Like Item 2.02, this information is generally "furnished" rather than "filed".
• Item 8.01: Other Events
  A voluntary disclosure of an event the company considers important to security holders that no other Item covers, such as a dividend declaration, a buyback program, litigation updates or product news.
• Item 9.01: Financial Statements and Exhibits
  Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.

Documents

This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.